Increased cerebrospinal fluid levels of transforming growth factor-β1 in Alzheimer’s disease
- 19 June 2004
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 367 (2) , 194-196
- https://doi.org/10.1016/j.neulet.2004.06.001
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Transforming Growth Factor-β1 Potentiates Amyloid-β Generation in Astrocytes and in Transgenic MiceJournal of Biological Chemistry, 2003
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Analysis of genetic polymorphisms in the transforming growth factor-?1 gene and the risk of Alzheimer's diseaseHuman Genetics, 2000
- Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSFNeurology, 1999
- Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.Proceedings of the National Academy of Sciences, 1994
- Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1β in astrocytesMolecular Brain Research, 1993
- Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's diseaseBiochemical and Biophysical Research Communications, 1990
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975